Market Executive Summary

Advanced cell-based therapies are promising approaches for stimulating full regeneration of cartilage lesions.

Due to the COVID-19 pandemic, the global Advanced Cell Therapies market size was US$ 12 billion in 2022 and is forecast to a readjusted size of US$ 82 billion by 2029 with a CAGR of 20.80% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Stem Cell Transplants accounting for % of the Advanced Cell Therapies global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Stem Cell segment is altered to an ?GR throughout this forecast period.

The global key companies of Advanced Cell Therapies include FRC Blood Service, Fujifilm, Vericel, Advanced Cell Technology, Inc, Locate Bio Limited, Kolon TissueGene, Gamida Cell, Okyanos and Rexgenero, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

The United States Advanced Cell Therapies market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2029, trailing a CAGR of % through the analysis period. As for the Europe Advanced Cell Therapies landscape, Germany is projected to reach US$ million by 2029. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Advanced Cell Therapies market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Advanced Cell Therapies market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Advanced Cell Therapies market. Readers of the report can become informed about current and future trends of the global Advanced Cell Therapies market and how they will impact market growth during the forecast period.

By Company

    FRC Blood Service

    Fujifilm

    Vericel

    Advanced Cell Technology, Inc

    Locate Bio Limited

    Kolon TissueGene

    Gamida Cell

    Okyanos

    Rexgenero

    BioXcellerator

    Takura

    Autolus

Segment by Type

    Stem Cell Transplants

    CAR T-cell Therapy

Segment by Application

    Stem Cell

    Regenerative Medicine

By Region

    North America

        United States

        Canada

    Europe

        Germany

        France

        U.K.

        Italy

        Russia

    Asia-Pacific

        China

        Japan

        South Korea

        India

        Australia

        China Taiwan

        Indonesia

    Latin America

        Mexico

        Brazil

        Argentina

    Middle East & Africa

        Turkey

        Saudi Arabia

        UAE

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.

Chapter 2: Revenue of Advanced Cell Therapies in global and regional level.

Chapter 3: Detailed analysis of Advanced Cell Therapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.

Chapter 9: Latin America by type, by application and by country, revenue for each segment.

Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Cell Therapies revenue, gross margin, and recent development, etc.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: Research Findings and Conclusion